nach oben

Erschienen in:

01.06.2004 | Original Article

Reduction of PTEN and p27^kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies

verfasst von: Tina Dreher, Hanswalter Zentgraf, Ulrich Abel, Alexandra Kappeler, Maurice S. Michel, Uwe Bleyl, Rainer Grobholz

Erschienen in: Virchows Archiv | Ausgabe 6/2004

Einloggen, um Zugang zu erhalten

Abstract

The extreme variability of prostate cancer implies latent disease with missing clinical symptoms in some cases. Tumor suppressors PTEN (phosphatase and tensin homolog deleted on chromosome ten) and p27^kip1 are frequently mutated in various human cancers. PTEN negatively influences cell growth and induces apoptosis, while p27^kip1 binds to cyclin-E-Cdk2 and counteracts mitosis. This study investigated the expression of PTEN and p27^kip1 in prostatectomies and needle biopsies in order to determine whether protein localization or expression levels are correlated with tumor grade and whether PTEN and p27^kip1 expression in biopsies are valuable predictive tumor markers. Analysis of PTEN demonstrated that weak expression levels were significantly more prevalent in high-grade tumors. Analysis of p27^kip1 revealed that high-grade tumors had a higher percentage of cytoplasmic localization of the protein than low-grade tumors, where nuclear localization was more frequent. Furthermore, this study indicated a positive association between PTEN and p27^kip1 levels. An increase of high-grade tumors corresponded to a progressive loss of both tumor suppressors in needle biopsies and prostatectomies. p27^kip1 and PTEN did not show a higher predictive accuracy of the tumor grade in the surgical specimen than the Gleason score. However, p27^kip1 had the same predictive value as the Gleason score in needle biopsies.

Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L (1997) Decreased levels of the cell-cycle inhibitor p27^kip1 protein: prognostic implications in primary breast cancer. Nat Med 3:227–230PubMed

Dahia PL, Aguiar RC, Alberta J, Kum JB, Caron S, Sill H, Marsh DJ, Ritz J, Freedman A, Stiles C (1999) PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanisms in haematological malignancies. Hum Mol Genet 8:185–193CrossRefPubMed

Di Cristofano A, Pandolfi PP (2000) The multiple roles of PTEN in tumor suppression. Cell 100:387–390PubMed

Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP (2001) PTEN and p27^kip1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 27:222–224CrossRefPubMed

Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L (2000) Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27^kip1. Mol Cell Biol 20:9138–9148CrossRefPubMed

Freedland SJ, deGregorio F, Sacoolidge JC, Elshimali YI, Csathy GS, Dorey F, Reiter RE, Aronson WJ (2003) Preoperative p27^kip1 status is an independent predictor of prostate specific antigen failure following radical prostatectomy. J Urol 169:1325–1330PubMed

Gleason DF (1992) Histologic grading of prostate cancer: a perspective. Hum Pathol 23:273–279PubMed

Hengst L, Reed SI (1996) Translational control of p27^kip1 accumulation during the cell cycle. Science 271:1861–1864PubMed

Jemal A, Momas A, Murray T, Thun M (2002) Cancer statistics, 2002. CA Cancer J Clin 52:23–47PubMed

10.

Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497PubMed

11.

Kuczyk M, Machtens S (1999) Predictive value of decreased p27^kip1 protein expression for the recurrence-free and long-term survival of prostate cancer patients. Br J Cancer 81:1052–1058CrossRefPubMed

12.

Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275:1943–1947PubMed

13.

Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R (2002) PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8:1153–1160CrossRefPubMed

14.

Liao Y, Grobholz R, Abel U, Trojan L, Michel MS, Angel P, Mayer D (2003) Increase of AKT/PKB expression correlates with Gleason pattern in human prostate cancer. Int J Cancer 107:676–680CrossRefPubMed

15.

McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Sellers WR (1999) Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res 59:4291–4296PubMed

16.

Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP, Eng C (2000) Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 92:924–930CrossRefPubMed

17.

Nelen MR, van Staveren WC, Peeters EA, Hassel MB, Gorlin RJ, Hamm H, Lindboe CF, Fryns JP, Sijmons RH, Woods DG (1997) Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 6:1383–1387PubMed

18.

Ramaswarny S, Sellers WR (2000) PTEN: a prostate cancer tumor-suppressor gene. Prostate J 2:55–61CrossRef

19.

Ramaswamy S, Nakamura N, Vazquez F, Batt DB, Perera S, Roberts TM, Sellers WR (1999) Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 96:2110–2115CrossRefPubMed

20.

Reynisdottir I, Massague J (1997) The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 11:492–503PubMed

21.

Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S (2001) p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J 20:6672–6682CrossRefPubMed

22.

Sherr CJ (1996) Cancer cell cycles. Science 274:1672–1677PubMed

23.

Shin I, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL (2002) PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Nat Med 8:1145–1152CrossRefPubMed

24.

Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T (1997) Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356–362PubMed

25.

Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL (1997) MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57:5221–5225PubMed

26.

True LD (1994) Surgical pathology examination of the prostate gland. Practice survey by American Society of Clinical Pathologists. Am J Clin Pathol 102:572–579PubMed

27.

Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N, Sellers WR (2001) Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276:48627–48630CrossRefPubMed

28.

Verbeke CS, Wenthe U, Grobholz R, Zentgraf H (2001) Fas ligand expression in Hodgkin lymphoma. Am J Surg Pathol 25:388–394PubMed

29.

Viglietto G, Motti ML, Bruni P, Melillo RM, D’Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A (2002) Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8:1136–1144CrossRefPubMed

30.

Vis AN, Noordzij MA, Fitoz K, Wildhagen MF, Schroder FH, van der Kwast TH (2000) Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer. J Urol 164:2156–2161CrossRefPubMed

31.

Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL (1998) The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 95:15587–15591PubMed

Titel: Reduction of PTEN and p27kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies
verfasst von: Tina Dreher
Hanswalter Zentgraf
Ulrich Abel
Alexandra Kappeler
Maurice S. Michel
Uwe Bleyl
Rainer Grobholz
Publikationsdatum: 01.06.2004
Verlag: Springer-Verlag
Erschienen in: Virchows Archiv / Ausgabe 6/2004
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI: https://doi.org/10.1007/s00428-004-1004-6

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Reduction of PTEN and p27^kip1 expression correlates with tumor grade in prostate cancer. Analysis in radical prostatectomy specimens and needle biopsies

Abstract

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2004

New cell lines with chondrocytic phenotypes from human chondrosarcoma

June 2004

Transforming growth factor β1-induced glomerulopathy is prevented by 17β-estradiol supplementation

Pyogenic granuloma: an unrecognized cause of gastrointestinal bleeding

Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptors

Electron microscopy and immunohistochemistry studies of pulmonary carcinosarcomas expressing the transcription factor MEF-2 and showing significant cell-to-cell, cell-to-matrix, and epithelial–mesenchymal interactions

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Vergleichende Pathologie in der onkologischen Forschung

Gastrointestinale Stromatumoren

Personalisierte Medizin in der Onkologie